News

Patients with psoriasis generally prefer the standard of care over teledermatology, but certain attributes change patient preferences.
Symptoms, lesion locations, and morphology are among the features clinicians may use to distinguish hand eczema from hand psoriasis in patients.
Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.
Those who are not considered "high risk" will be ineligible for future COVID-19 booster vaccines that have not undergone extra testing.
Patients with varicose veins have a higher risk for all-cause dementia, while treatment of varicose veins is tied to a lower risk for vascular dementia.
Herpes simplex virus type 1 is linked to Alzheimer disease, although the risk is lower with use of antiherpetics.
The FDA has ordered Pfizer and Moderna to amend the warning labels on their COVID-19 vaccines with risk of myocarditis and pericarditis.
Delgocitinib cream is more effective and has a better safety profile than oral alitretinoin for the treatment of severe chronic hand eczema.
Anti-OX40 medications have been associated with positive efficacy and safety outcomes for the treatment of atopic dermatitis.
A radionuclide treatment for non-melanoma skin cancer is well tolerated and effective for patients with shallow skin lesions, according to researchers.
Complications from flap reconstructions 60 cm2 or greater in the outpatient dermatology setting are infrequent and nonlife threatening.
Despite medical innovations, maternal mortality rates in the US remain high, especially compared with those of similarly wealthy countries.